Please Wait.....
Report
Global Urology Laser Market - Industry Trends and Forecast to 2030
Market Report I 2023-04-01 I 180 Pages I Data Bridge Market Research
Global urology laser market is expected to reach USD 1,637,949.81 thousand by 2030 from USD 1,050,000.00 thousand in 2022, growing at a CAGR of 5.7% during the forecast period of 2023 to 2030.
Market Segmentation:
Global Urology Laser Market, By Laser Type (Holmium Yttrium Aluminum Garnet (Ho:Yag), Thulium Yttrium Aluminum Garnet (Thu:Yag), Neodymium-Doped Yttrium Aluminum Garnet (Nd:Yag), Potassium Titanyl Phosphate Yttrium Aluminum Garnet (Ktp:Yag), Diode Laser, Erbium: Yttrium Aluminum Garnet Laser, Lithium Borate, and Others), Modality (Portable, Standalone), Application (Urolithiasis, Benign Prostatic Hyperplasia (BPH), Partial Kidney Resection, Removal of Kidney Stones, Urethral Strictures, Tumors, and Others), End User (Hospitals, Urological Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retails Sales, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Colombia, Peru, Chile, Ecuador, Uruguay, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, Kuwait, Qatar, Nigeria, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Global Urology Laser Market Dynamics :
Driver
- Rising number of patients related to urology disorders globally
Restrain
- High cost of urology laser device and procedure
Opportunity
- Technological advancements in laser technology
Market Players:
Some of the key market players operating in the global urology laser market are listed below:
- Boston Scientific Corporation or its affiliates
- Cook
- Olympus Corporation
- Coherent, Inc.
- Dornier MedTech
- Richard Wolf GmbH
- OmniGuide Holdings, Inc.
- BD
- Allengers
- Quanta System
- Gigaalaser
- EMS Urology
- Convergent Laser Technologies
- Trimedyne, Inc
- Limmer Laser GmbH
- MONOCROM
- INTERmedic Arfran
- Advin Urology
- Rocamed
- Hyperphotonics
- BISON MEDICAL
- biolitec AG
- Surgical Lasers Inc.
- Potent Medical
- Healthware Pvt Ltd
- Unique Medical Devices
TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF THE GLOBAL UROLOGY LASER MARKET 17
1.4 CURRENCY AND PRICING 19
1.5 LIMITATIONS 19
1.6 MARKETS COVERED 19
2 MARKET SEGMENTATION 23
2.1 MARKETS COVERED 23
2.2 GEOGRAPHICAL SCOPE 24
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 DBMR TRIPOD DATA VALIDATION MODEL 26
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.6 MULTIVARIATE MODELLING 30
2.7 PRODUCT TYPE LIFELINE CURVE 30
2.8 DBMR MARKET POSITION GRID 31
2.9 VENDOR SHARE ANALYSIS 33
2.10 MARKET END USER COVERAGE GRID 34
2.11 SECONDARY SOURCES 35
2.12 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHT 39
4.1 PESTEL ANALYSIS 41
4.2 PORTER'S FIVE FORCES 42
4.3 IMPORT-EXPORT ANALYSIS 43
4.3.1 IMPORT 43
4.3.1.1 INDIA 43
4.3.2 EXPORT 43
4.4 STRATEGIC INITIATIVES 44
4.5 PRICING ANALYSIS 45
4.6 ADOPTION OF LASER 45
5 GLOBAL UROLOGY LASER MARKET, EPIDEMIOLOGY 47
5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY 47
5.2 UROLITHIASIS 47
5.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 48
5.4 PARTIAL KIDNEY RESECTION 50
5.5 KIDNEY STONES 50
5.6 URETHRAL STRICTURES 51
5.7 TUMORS 51
6 GLOBAL UROLOGY LASER MARKET, REGULATIONS 52
6.1 REGULATORY SCENARIO IN THE U.S. 52
6.2 REGULATORY SCENARIO IN AUSTRALIA 52
6.3 REGULATORY SCENARIO IN INDIA 53
6.4 REGULATORY SCENARIO IN U.K. 54
7 MARKET OVERVIEW 55
7.1 DRIVERS 57
7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS GLOBALLY 57
7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES 57
7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES 57
7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES 58
7.2 RESTRAINTS 59
7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE 59
7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS 59
7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS 59
7.3 OPPORTUNITIES 60
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY 60
7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS 61
7.4 CHALLENGES 61
7.4.1 LACK OF SKILLED PROFESSIONALS 61
7.4.2 STRINGENT REGULATIONS 62
8 GLOBAL UROLOGY LASER MARKET, BY LASER TYPE 63
8.1 OVERVIEW 64
8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 67
8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 67
8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 68
8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 68
8.6 DIODE LASER 69
8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 69
8.8 LITHIUM BORATE 70
8.9 OTHERS 70
9 GLOBAL UROLOGY LASER MARKET, BY MODALITY 71
9.1 OVERVIEW 72
9.2 PORTABLE 75
9.3 STANDALONE 75
10 GLOBAL UROLOGY LASER MARKET, BY APPLICATION 76
10.1 OVERVIEW 77
10.2 UROLITHIASIS 80
10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 80
10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 81
10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 81
10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 81
10.2.5 DIODE LASER 81
10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 81
10.2.7 LITHIUM BORATE 81
10.2.8 OTHERS 81
10.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 81
10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 82
10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 82
10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 83
10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 83
10.3.5 DIODE LASER 83
10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 83
10.3.7 LITHIUM BORATE 83
10.3.8 OTHERS 83
10.4 PARTIAL KIDNEY RESECTION 83
10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 84
10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 84
10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 84
10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 84
10.4.5 DIODE LASER 84
10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 85
10.4.7 LITHIUM BORATE 85
10.4.8 OTHERS 85
10.5 REMOVAL OF KIDNEY STONES 85
10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 86
10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 86
10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 86
10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 86
10.5.5 DIODE LASER 86
10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 86
10.5.7 LITHIUM BORATE 87
10.5.8 OTHERS 87
10.6 URETHRAL STRICTURES 87
10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 88
10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 88
10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 88
10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 88
10.6.5 DIODE LASER 88
10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 88
10.6.7 LITHIUM BORATE 89
10.6.8 OTHERS 89
10.7 TUMORS 89
10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 90
10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 90
10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 90
10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 90
10.7.5 DIODE LASER 90
10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 90
10.7.7 LITHIUM BORATE 90
10.7.8 OTHERS 90
10.8 OTHERS 90
10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 91
10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 91
10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 92
10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 92
10.8.5 DIODE LASER 92
10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 92
10.8.7 LITHIUM BORATE 92
10.8.8 OTHERS 92
11 GLOBAL UROLOGY LASER MARKET, BY END USER 93
11.1 OVERVIEW 94
11.2 HOSPITALS 97
11.3 UROLOGICAL CLINICS 97
11.4 AMBULATORY SURGICAL CENTERS 97
11.5 OTHERS 98
12 GLOBAL UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL 99
12.1 OVERVIEW 100
12.2 DIRECT TENDER 103
12.3 RETAIL SALES 103
12.4 ONLINE SALES 103
12.5 OTHERS 104
13 GLOBAL UROLOGY LASER MARKET, BY REGION 105
13.1 OVERVIEW 106
13.2 NORTH AMERICA 111
13.2.1 U.S. 115
13.2.2 CANADA 115
13.2.3 MEXICO 115
13.3 EUROPE 116
13.3.1 GERMANY 120
13.3.2 U.K. 120
13.3.3 ITALY 120
13.3.4 FRANCE 120
13.3.5 SPAIN 120
13.3.6 RUSSIA 120
13.3.7 SWITZERLAND 120
13.3.8 TURKEY 120
13.3.9 BELGIUM 120
13.3.10 NETHERLANDS 120
13.3.11 REST OF EUROPE 120
13.4 ASIA-PACIFIC 121
13.4.1 JAPAN 125
13.4.2 CHINA 125
13.4.3 SOUTH KOREA 125
13.4.4 INDIA 125
13.4.5 AUSTRALIA 125
13.4.6 SINGAPORE 125
13.4.7 THAILAND 125
13.4.8 INDONESIA 125
13.4.9 MALAYSIA 125
13.4.10 PHILIPPINES 125
13.4.11 REST OF ASIA-PACIFIC 125
13.5 SOUTH AMERICA 126
13.5.1 BRAZIL 130
13.5.2 ARGENTINA 130
13.5.3 COLOMBIA 130
13.5.4 PERU 130
13.5.5 CHILE 130
13.5.6 ECUADOR 130
13.5.7 URUGUAY 130
13.5.8 REST OF SOUTH AMERICA 130
13.6 MIDDLE EAST AND AFRICA 131
13.6.1 SOUTH AFRICA 135
13.6.2 SAUDI ARABIA 135
13.6.3 U.A.E. 135
13.6.4 ISRAEL 135
13.6.5 EGYPT 135
13.6.6 KUWAIT 135
13.6.7 QATAR 135
13.6.8 NIGERIA 135
13.6.9 REST OF MIDDLE EAST AND AFRICA 135
14 GLOBAL UROLOGY LASER MARKET, COMPANY LANDSCAPE 136
14.1 COMPANY SHARE ANALYSIS: GLOBAL 136
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 137
14.3 COMPANY SHARE ANALYSIS: EUROPE 138
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 139
15 SWOT ANALYSIS 140
16 COMPANY PROFILE 141
16.1 BOSTON SCIENTIFIC CORPORATION 141
16.1.1 COMPANY SNAPSHOT 141
16.1.2 REVENUE ANALYSIS 141
16.1.3 COMPANY SHARE ANALYSIS 142
16.1.4 PRODUCT PORTFOLIO 142
16.1.5 RECENT DEVELOPMENT 142
16.2 COOK 144
16.2.1 COMPANY SNAPSHOT 144
16.2.2 COMPANY SHARE ANALYSIS 144
16.2.3 PRODUCT PORTFOLIO 145
16.2.4 RECENT DEVELOPMENT 145
16.3 OLYMPUS CORPORATION 146
16.3.1 COMPANY SNAPSHOT 146
16.3.2 REVENUE ANALYSIS 146
16.3.3 COMPANY SHARE ANALYSIS 147
16.3.4 PRODUCT PORTFOLIO 147
16.3.5 RECENT DEVELOPMENT 147
16.4 COHERENT, INC. 148
16.4.1 COMPANY SNAPSHOT 148
16.4.2 REVENUE ANALYSIS 148
16.4.3 COMPANY SHARE ANALYSIS 149
16.4.4 PRODUCT PORTFOLIO 149
16.4.5 RECENT DEVELOPMENT 149
16.5 DORNIER MEDTECH 150
16.5.1 COMPANY SNAPSHOT 150
16.5.2 COMPANY SHARE ANALYSIS 150
16.5.3 PRODUCT PORTFOLIO 151
16.5.4 RECENT DEVELOPMENT 151
16.6 ADVIN HEALTH CARE 152
16.6.1 COMPANY SNAPSHOT 152
16.6.2 PRODUCT PORTFOLIO 152
16.6.3 RECENT DEVELOPMENTS 152
16.7 ALLENGERS 153
16.7.1 COMPANY SNAPSHOT 153
16.7.2 PRODUCT PORTFOLIO 153
16.7.3 RECENT DEVELOPMENT 153
16.8 BD 154
16.8.1 COMPANY SNAPSHOT 154
16.8.2 REVENUE ANALYSIS 154
16.8.3 PRODUCT PORTFOLIO 155
16.8.4 RECENT DEVELOPMENTS 155
16.9 BIOLITEC AG 156
16.9.1 COMPANY SNAPSHOT 156
16.9.2 PRODUCT PORTFOLIO 156
16.9.3 RECENT DEVELOPMENT 156
16.10 BISON MEDICAL 157
16.10.1 COMPANY SNAPSHOT 157
16.10.2 PRODUCT PORTFOLIO 157
16.10.3 RECENT DEVELOPMENTS 157
16.11 CONVERGENT LASER TECHNOLOGIES 158
16.11.1 COMPANY SNAPSHOT 158
16.11.2 PRODUCT PORTFOLIO 158
16.11.3 RECENT DEVELOPMENTS 158
16.12 EMS UROLOGY 159
16.12.1 COMPANY SNAPSHOT 159
16.12.2 PRODUCT PORTFOLIO 159
16.12.3 RECENT DEVELOPMENTS 159
16.13 GIGAALASER 160
16.13.1 COMPANY SNAPSHOT 160
16.13.2 PRODUCT PORTFOLIO 160
16.13.3 RECENT DEVELOPMENTS 160
16.14 HEALTHWARE PVT LTD. 161
16.14.1 COMPANY SNAPSHOT 161
16.14.2 PRODUCT PORTFOLIO 161
16.14.3 RECENT DEVELOPMENT 161
16.15 HYPERPHOTONICS. 162
16.15.1 COMPANY SNAPSHOT 162
16.15.2 PRODUCT PORTFOLIO 162
16.15.3 RECENT DEVELOPMENT 162
16.16 INTERMEDIC ARFRAN 163
16.16.1 COMPANY SNAPSHOT 163
16.16.2 PRODUCT PORTFOLIO 163
16.16.3 RECENT DEVELOPMENT 163
16.17 LIMMER LASER GMBH 164
16.17.1 COMPANY SNAPSHOT 164
16.17.2 PRODUCT PORTFOLIO 164
16.17.3 RECENT DEVELOPMENTS 164
16.18 MONOCROM 165
16.18.1 COMPANY SNAPSHOT 165
16.18.2 PRODUCT PORTFOLIO 165
16.18.3 RECENT DEVELOPMENT 165
16.19 OMNIGUIDE HOLDINGS, INC. 166
16.19.1 COMPANY SNAPSHOT 166
16.19.2 PRODUCT PORTFOLIO 166
16.19.3 RECENT DEVELOPMENTS 166
16.20 POTENT MEDICAL. 168
16.20.1 COMPANY SNAPSHOT 168
16.20.2 PRODUCT PORTFOLIO 168
16.20.3 RECENT DEVELOPMENT 168
16.21 QUANTA SYSTEM 169
16.21.1 COMPANY SNAPSHOT 169
16.21.2 PRODUCT PORTFOLIO 169
16.21.3 RECENT DEVELOPMENT 169
16.22 RICHARD WOLF GMBH. 170
16.22.1 COMPANY SNAPSHOT 170
16.22.2 PRODUCT PORTFOLIO 170
16.22.3 RECENT DEVELOPMENTS 170
16.23 ROCAMED 172
16.23.1 COMPANY SNAPSHOT 172
16.23.2 PRODUCT PORTFOLIO 172
16.23.3 RECENT DEVELOPMENTS 172
16.24 SURGICAL LASERS INC. 173
16.24.1 COMPANY SNAPSHOT 173
16.24.2 PRODUCT PORTFOLIO 173
16.24.3 RECENT DEVELOPMENT 173
16.25 TRIMEDYNE, INC. 174
16.25.1 COMPANY SNAPSHOT 174
16.25.2 PRODUCT PORTFOLIO 174
16.25.3 RECENT DEVELOPMENT 174
16.26 UNIQUE MEDICAL DEVICES 175
16.26.1 COMPANY SNAPSHOT 175
16.26.2 PRODUCT PORTFOLIO 175
16.26.3 RECENT DEVELOPMENTS 175
17 QUESTIONNAIRE 176
18 RELATED REPORTS 180
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security